Drug recall · August 8, 2012
Caziant recall
Why: Impurities/Degradation Products: High Out-of-specification results were obtained for both known and unknown impurities.
Class III: unlikely to cause harm, but breaks the rules (for example a labeling error).
The recall
- Product
Caziant (desogestrel and ethinyl estradiol) Tablets, USP, (Triphasic Regimen), 0.1 mg/0.025 mg, 0.125 mg/0.025 mg, 0.15 mg/0.025 mg, 28-count tablets per dispenser (NDC 52544-959-28), packaged in 3-count Tablet Dispensers per carton (NDC 52544-959-31), Rx only Manufactured by: Watson Laboratories, Inc., Corona, CA 92880; Distributed by: Watson Pharma, Inc., Corona, CA 92880.
- Lots / codes
Lot #s: 412572A, 412572B, Exp 11/12
- Quantity
- 18,938 cartons
- Company
- Watson Laboratories Inc, Corona, CA
- Distribution
- Nationwide.
- Initiated
- June 5, 2012 · Voluntary: Firm initiated
- Classified
- August 1, 2012
- Reported
- August 8, 2012
- Ended
- March 18, 2013
- How notified
- Letter
The drug: prices, other makers, shortages
If you have this product
- Check the lot number on your package against the lots above. Only those lots are recalled.
- Don't stop a prescription medicine on your own. Call your pharmacy - they can swap it for an unaffected lot or another maker.
- Felt unwell? Contact your doctor, and report it to FDA MedWatch (1-800-FDA-1088 or fda.gov/medwatch).
- Return or dispose of recalled product as the company or your pharmacy advises.
Questions about this recall
No comments yet. Questions, tips, what worked for you - start the conversation.
Watch Estradiol
One email when the price moves, a recall or shortage is posted, or the label changes. Plus the monthly biggest-movers report. Unsubscribe in one click.